Publication | Closed Access

Pharmacological manipulation of Ezh2 with salvianolic acid B results in tumor vascular normalization and synergizes with cisplatin and T cell-mediated immunotherapy

OncologyT Cell-mediated ImmunotherapyMedicinePharmacological ManipulationAnti-cancer AgentTumor Vascular NormalizationCancer TreatmentPharmacologyCell BiologyTumor Microenvironment